Fig. 6From: Composite endpoints, including patient reported outcomes, in rare diseasesResponses of the participants to the EJP RD webinar (n = 65) to the question: How often is, in your experience, a patient relevant outcome, such as quality of life, important for the evaluation of a treatment effect?Back to article page